Premium
The reproductive conditions and lipid profile in females with epilepsy
Author(s) -
Hamed S. A.,
Hamed E. A.,
Shokry M.,
Omar H.,
Abdellah M. M.
Publication year - 2007
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.2006.00740.x
Subject(s) - prolactin , epilepsy , endocrinology , medicine , testosterone (patch) , luteinizing hormone , hormone , follicle stimulating hormone , polycystic ovary , carbamazepine , physiology , lipid profile , cholesterol , insulin , insulin resistance , psychiatry
Objective – To explore the reproductive conditions in women with epilepsy. Methods – Eighty‐eight women were included; 37.5% and 62.5% had generalized and partial epilepsies, respectively. Ovarian sonogram, reproductive hormone and lipid profiles were assessed. Results – Compared with the control group and in accordance with our laboratory reference values, irregular menses and polycystic ovaries (PCO(s)) were reported in 70.5% and 39.8% versus 21.7% and 16.7% of controls. Abnormalities in leutinizing hormone (LH), follicle‐stimulating hormone (FSH), LH‐to‐FSH ratio, testosterone (T) and prolactin (PRL) were identified. High values of FSH, LH and FSH‐to‐LH ratio were common with carbamazepine while that of T and PRL were common in untreated patients and with valproate. Low levels of high‐density lipoprotein cholesterol was identified in ∼59% but neither associated with duration and type of antiepileptic drugs nor patients’ age, hormonal profile or PCO(s). Significant correlation was identified between menatrual irregularities, T, PRL, hormonal, lipid profile alterations, PCO(s) and seizure frequency but neither with epilepsy type nor focus. Conclusion – This is the first study in our country that aimed at evaluation of reproductive conditions in women with epilepsy. This study indicates that reproductive dysfunction is common, hence, characterization of seizure‐associated neuroendocrine adverse effects is important while managing women particularly during choice of antiepileptic medications as initial step and during patients’ follow‐up.